Axq Capital, LP Gilead Sciences, Inc. Transaction History

Axq Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $179,409 - $207,052	-2,841 Reduced 11.6%	21,659 $1.49 Billion
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $1.75 Million - $2.14 Million	24,500 New	24,500 $1.79 Billion
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $782,302 - $1.12 Million	12,553 New	12,553 $1.08 Billion

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Axq Capital, LP with notifications on news.